Emerging and Reemerging Infectious Diseases Journal Articles

• Diagnostic Approach and Update on Encephalitis Despite comprehensive testing, in some cases encephalitis can remain a diagnostic challenge. What strategies should be considered when initial testing is still unclear?
  Current Opinion in Infectious Diseases, July 05, 2022
• Tuberculosis -- United States, 2021 Tuberculosis incidence decreased nearly 20% in 2020, coinciding with the COVID-19 pandemic. What might be the explanation for this sharp decrease?
  Morbidity & Mortality Weekly Report, June 17, 2022
• Musculoskeletal Tuberculosis: Diagnosis and Treatment Learn more about the diagnostic and treatment strategies to consider for this rare presentation of tuberculosis.
  Journal of Clinical Rheumatology, June 17, 2022
• Hospitalization of Infants and Children 0-4 Years With COVID-19 This study details COVID-19-associated hospitalization rates among infants and children aged 0-4 years and how they have trended over the course of the pandemic.
  Morbidity & Mortality Weekly Report, June 15, 2022
• Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 Prior reports have suggested cross-reactivity between assays for SARS-CoV2, dengue, and Zika viruses, but this report indicates high specificity and minimal levels of cross-reactivity among the three.
  Morbidity & Mortality Weekly Report, June 06, 2022
• Breast Milk as Route of Tick-Borne Encephalitis Transmission Could mothers transmit tick-borne encephalitis virus to their infants through breastfeeding?
  Emerging Infectious Diseases, June 01, 2022
• Expansion of ACIP Ebola Vaccine Recommendations The ACIP has expanded recommendations for Ebola vaccination to include groups who are at high risk for occupational exposure.
  Morbidity & Mortality Weekly Report, May 25, 2022
• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Decrease in Tuberculosis Cases During COVID-19 Pandemic An analysis of prescription data noted a significant decline in reported tuberculosis cases during the COVID-19 pandemic. What factors may account for the downward trend?
  Emerging Infectious Diseases, May 04, 2022
• Acute Kidney Injury is Linked to Neurocognitive Impairments A new study finds that an episode of acute kidney injury could have negative impacts on neurocognitive functioning.
  Nephrology Dialysis Transplantation, May 04, 2022
• A Young Adolescent With MIS-C-Like Illness During COVID-19 A young patient presents with MIS-C-like symptoms but no known history of or exposure to COVID-19. What differential diagnoses should be considered?
  Pediatric Nursing, May 02, 2022
• SGLT2 Inhibitors: The Statins of the 21st Century This overview of the development and clinical applications of SGLT2 inhibitors positions them as one of the major pharmacological advances in cardiovascular medicine in this century.
  European Heart Journal, April 19, 2022
• Overseas Treatment of Latent TB in US-Bound Immigrants Could TB testing and treatment of immigrants before arrival in the U.S. help prevent the importation of the disease?
  Emerging Infectious Diseases, March 22, 2022
• Outcomes in Those Aged <18 Years Hospitalized With COVID-19 Many pediatric patients in this study with COVID-19-related hospitalization had severe illness and viral coinfections, and few had been vaccinated, according to this CDC report.
  Morbidity & Mortality Weekly Report, March 21, 2022
• Safety and Efficacy of Tofacitinib for Ulcerative Colitis This paper presents final data from OCTAVE Open, an open-label, long-term extension study on the safety and efficacy of the Janus kinase inhibitor tofacitinib for the treatment of ulcerative colitis.
  Alimentary Pharmacology & Therapeutics, March 08, 2022
• Immunosuppression Withdrawal After Lupus Nephritis Remission In lupus nephritis patients in remission, could immunosuppressive therapy be safely withdrawn?
  Rheumatology, March 03, 2022
• Impact of COVID-19 on HIV Testing and Care Provision The significant impacts of the COVID-19 pandemic on access to HIV testing and treatment could have long-term consequences.
  HIV Medicine, February 24, 2022
• West Nile Virus Transmission by Solid Organ Transplantation Due to the potential for West Nile virus transmission through solid organ transplantation, should routine donor screening be considered?
  Emerging Infectious Diseases, February 23, 2022
• Zoonotic Infection With Oz Virus, a Novel Thogotovirus Learn more about the Oz virus, a tick-transmitted thogotovirus that could potentially cause infection in mammals -- including humans.
  Emerging Infectious Diseases, February 18, 2022